Evidence map›Paper›PMID 29432066›Full record

Trial reportLymphatic research and biology2018

Evaluation of CT Changes in the Head and Neck After Cancer Treatment: Development of a Measurement Tool.

Joseph M Aulino, Elizabeth M Wulff-Burchfield, Mary S Dietrich, Sheila H Ridner, Kenneth J Niermann, Jie Deng, Bethany A Rhoten, Jennifer K Doersam, Lee Ann Jarrett, Kyle Mannion and 1 more

Open access · greenAbstract readClinical Trial
In one paragraph

Trial report in Lymphatic research and biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. A systematic review of validated assessments methods for head and neck lymphedema.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2023
    Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Joseph M Aulino1 Division of Neuroradiology, Department of Radiology and Radiological Sciences, Vanderbilt University Medical Center , Nashville, Tennessee.
Elizabeth M Wulff-Burchfield2 Department of Medicine, Vanderbilt University Medical Center , Nashville, Tennessee.
Mary S Dietrich2 Department of Medicine, Vanderbilt University Medical Center , Nashville, Tennessee.
Sheila H Ridner3 School of Nursing, Vanderbilt University Medical Center , Nashville, Tennessee.
Kenneth J Niermann4 Department of Radiation Oncology, Vanderbilt University Medical Center , Nashville, Tennessee.
Jie Deng3 School of Nursing, Vanderbilt University Medical Center , Nashville, Tennessee.
Bethany A Rhoten3 School of Nursing, Vanderbilt University Medical Center , Nashville, Tennessee.
Jennifer K Doersam3 School of Nursing, Vanderbilt University Medical Center , Nashville, Tennessee.
Lee Ann Jarrett5 College of Nursing, East Carolina University , Greenville, North Carolina.
Kyle Mannion6 Department of Surgery, Vanderbilt University Medical Center , Nashville, Tennessee.
Barbara A Murphy2 Department of Medicine, Vanderbilt University Medical Center , Nashville, Tennessee.
Vanderbilt University Medical Center · USEast Carolina University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe late effect continuum of lymphedema and fibrosis (LEF) affects more than 70% of patients after treatment for head and neck cancer (HNC). LEF is associated with symptom burden and decreased function and quality of life. Although surveillance imaging is common posttreatment, objective assessment of soft tissues is not, likely due to the lack of objective evaluation methods and understanding of the significance of LEF. We undertook the development of a tool to measure LEF using CT scans in HNC patients. METHODS AND

resultsWe developed a CT measurement tool assessing sites of soft tissue damage secondary to tumor, surgery, or radiation. The tool was applied to pre- and posttreatment CT scans for 10 HNC patients. The data were reviewed, and the initial tool was modified. Ten additional patients' scans were assessed using the revised tool. The tool was modified further after data review by an expert panel and was then applied to scans from all 20 patients. The final tool included 11 items as follows: grading of fat stranding at 6 sites (axial reconstruction images, scale 0-2), measurement of epiglottic thickness (sagittal images, scale mm), and measurement of prevertebral soft tissue thickness at C3 (sagittal images, scale mm). A total of 176 CT scans were evaluated from 20 patients (range 4-14 examinations/patient). Preliminary data demonstrated face validity.

conclusionsThe final LEF assessment tool (CT-LEFAT) provides a standardized method for assessing critical sites that are involved by LEF. Studies to assess reliability and validity are ongoing.

Indexed as

Adipose TissueAdultAgedEpiglottisFemaleFibrosisHead and Neck NeoplasmsHumansLymphedemaMaleMiddle AgedMuscle, SkeletalQuality of LifeSpineTomography, X-Ray Computedcomputed tomographyepiglottishead and neck cancerlymphedemaprevertebral soft tissueradiation therapy

Identifiers

PMID29432066
PMCPMC5810430
OpenAlexW2788449131

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.